Resistance to antibiotics of Escherichia Coli, Enterobacter Gergoviae and Klebsiella Pneumoniae during urinary infections at CHUJRA Antananarivo, Madagascar
Abstract
Introduction: Infections of the urinary tract remain among the most common problems facing the clinician. This work aims to determine the antibiotic resistance of E. coli, E. gergoviae and K. pneumoniae during urinary tract infections in the Microbiology laboratory of the Joseph Ravoahangy Andrianavalona Antananarivo University Hospital Center to allow a better therapeutic approach.
Material & Methods: We carried out a retrospective and descriptive study on all of the E. coli, E. gergoviae and K. pneumoniae strains isolated from the urine of patients who attended the laboratory of Microbiology on CHUJRA Antananarivo with a suspected UTI between January 2004 and december 2014. Susceptibility to antibiotics was assessed by the disc diffusion technique on Mueller–Hinton agar (MH) or MH + 5% sheep blood, as recommended by the Antibiogram Committee of the French Microbiology Society as the antibiotics tested.
Results: E. coli, E. gergoviae and K. pneumoniae were isolated from 577 of the 5836 patients who submitted a urine sample (9.89%). Almost three quarters of isolates were E. coli (72.96%), E. gergoviae was found in 7.80% of cases and K. pneumoniae in 19.23% of cases.Ampicillin, amoxicillin + clavulanic acid, ticarcillin, first generation cephalosporins, second generation cephalosporins, cyclins, and cotrimoxazole represent a very high resistance level for E. coli, E. gergoviae and K. pneumoniae in the vast majority of cases. Since 2008, the presence of ESBL has been lower than in previous years (p=0.02). Antibiotics that remain effective in the majority of UTI cases are nitrofurans, colistin, imipenem, amikacin and Piperacillin / tazobactam.
Conclusions: These results confirm the presence of multi- resistant strains as in hospitals and community settings and the associated resistance to the most accessible antibiotics inevitably limits the choice of antibiotic in the establishment of adequate treatment.
Downloads
References
Dracon M, Lemaitre L. Urinary infection of children and adults - Leucocyturia. The practitioner's review. 2003;53(10):1137-1142.
Alvarez C, Pangon B, Allouch PY, Ghnassia JC. Infections urinaires : principaux aspect épidémiologiques, bactériologiques et cliniques. Feuillets Biol. 1992;23(189):15-24.
Skov R, Smyth R, Larsen AR, Bolmstrom A, Karlsson A, Mills K, Frimodt-Moller N. Antibiogram Committee of the French Society of Microbiology. SFM Recommendations 2007. 2007.
Ramilitiana B, Rakotoarivelo RA, Razafimahefa SH, Vololontiana D, Randrianarison A, Randria MJD et al. Prévalence de la résistance des bactéries aux antibiotiques dans les infections urinaires de l’adulte en milieu hospitalier à Antananarivo. Med Afr Noire. 2014 ;61(10):514-518.
Carron F, Galperine T, Dumarcet N, Azria R, Bingen E, Botto H et al. Diagnostic et antibiothérapie des IU bactériennes communautaire chez l’adulte. Elsevier Masson : médecine et maladies infectieuses. 2008:203-252.
Bourquia A, Ramdani B, Sahni K, Zaid D. Profile of urinary tract infection in a Nephrology department. Maghreb Med. 1992;33:11-12.
Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, et al. Antimicrobial resistance amonguropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007;59 (2):309-312. doi : https://doi.org/10.1093/jac/dkl466.
Vora S, Auckenthaler R. Que signifie « Béta-lactamaseà spectre élargi » en pratique? Rev Med Suisse. 2009; 5:1991-1994.
Rasamiravaka T, Rafanomezantsoa H, Rasoanandrasana S, Rakoto Alson AO, Rasamindrakotroka A. Présence préoccupante des bactéries multirésistantes dans la société malgache. Revue médicale de Madagascar. 2012 ; 2 (3):174-175.
Sekhsokh Y, Shaldy M, Hamzaoui E et al. Fréquence et sensibilité aux antibiotiques des bactéries isolées dans les urines. Médecine et maladies infectieuses. 2008;38(6):324-327.
Zahar J, Mamzer M, Kouatchet A. Contact isolation in the intensive care unit: why, when and adverse effects. Reanimation. 2011; 21(suppl 2):494-502
Grude N, TvetenY, Kristiansen B-E. Urinary tract infections in Norway: bacterialetiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect.2001;7(10):543-547.
El Mdaghri N, Belaïche A, Messaouidi D, Perrier-Gros-Claude JD, Benbachir M. Consommation d’antibiotiques et résistance des souches d’Escherichia coli isolées d’infections urinaires communautaires au Maroc. RICAI nos 1 et 2 décembre2005. 2005; Communication:101–240.
Levent T, Gauthier M, Dezorzi S, Paradis P, Alibert J, Bettoni C, Stock B. L'hygiène hospitalière et le conseil en antibiothérapie: un duo opérationnel face au problème de la diffusion des bactéries multirésistantes aux antibiotiques. Médecine et maladies infectieuses. 2005;35(9):443-449.
- Ministère de la Sante, du planning familial et de la protection sociale de Madagascar. Plan de développement secteur sante 2007-2011. Ministère de la Sante, du planning familial et de la protection sociale de Madagascar. 2007.
Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis. 1999;28(5):1062-1066. doi: 10.1086/514743.
Réseau BMR-Raisin. Réseau d’alerte, d’investigation et de surveillance des infections nosocomiales (raisin), surveillance des bactéries multi-résistantes dans les établissements de santé en France. Institut de veille sanitaire. 2012. http://www.invs.sante.fr/bmr-raisin.